Trial Profile

National multicenter cohort of patients with pandemic influenza (new A/H1N1v porcine virus)[Cohorte multicentrique nationale de patients atteints de grippe pand?mique (nouveau virus A/H1N1v d'origine porcine)]

Status: Recruiting

Phase of Trial: Phase IV

Latest Information Update: 16 Jun 2011

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Amantadine (Primary) ; Oseltamivir (Primary) ; Ribavirin (Primary) ; Zanamivir (Primary)
Indications Influenza A virus H1N1 subtype
Focus Therapeutic Use
Acronyms Etude Flu Co

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com